Teresa H. Evering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection”.

Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection

Annals of Internal Medicine(2023)10.7326/m22-2381

N/A

2.0DataRank · unranked

63 citations

Manish C. Choudhary, Carlee Moser, Justin Ritz, Eric S. Daar, David A. Wohl +41 more

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01254-1

N/A

1.6DataRank · unranked

53 citations

Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain +51 more

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

Annals of Internal Medicine(2023)10.7326/m22-3428

N/A

0.785DataRank · unranked

31 citations

Kara W Chew, Mark J Giganti, Carlee Moser, Mauricio Pinilla, David A. Wohl +76 more

One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial

Clinical Infectious Diseases(2023)10.1093/cid/ciad342

N/A

0.622DataRank · unranked

19 citations

Kara W Chew, Mark J Giganti, Eric S. Daar, David A. Wohl, Arzhang Cyrus Javan +47 more

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102250

N/A

0.587DataRank · unranked

12 citations

Kara W Chew, Mark J Giganti, Michael D. Hughes, Carlee Moser, Mark Main +79 more

Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019

Clinical Infectious Diseases(2022)10.1093/cid/ciac818

N/A

0.583DataRank · unranked

10 citations

Linda J Harrison, Kara W Chew, Judy Currier, David A. Wohl, Eric S. Daar +12 more

Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.10039

N/A

0.490DataRank · unranked

11 citations

Kara W Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan +47 more

Long COVID After Bamlanivimab Treatment

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad286

N/A

0.251DataRank · unranked

4 citations

Carlee Moser, Nikolaus Jilg, Eunice Yeh, Busola Sanusi, David A. Wohl +32 more

SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19

Clinical Infectious Diseases(2024)10.1093/cid/ciae324

N/A

0.189DataRank · unranked

2 citations

Mark J Giganti, Kara W Chew, Kathryn Shaw‐Saliba, Justin Ritz, Carlee Moser +10 more

Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae369

N/A

0.165DataRank · unranked

2 citations

Babafemi Taiwo, Carlee Moser, Eric S. Daar, David A. Wohl, Justin Ritz +46 more

Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.561

N/A

0DataRank · unranked

1 citations

Stacey J. Adam, Kevin W. Gibbs, Ari Moskowitz, Thomas L. Ortel, Upinder Singh +13 more

Viral and Symptom Rebound Following Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae501

N/A

0DataRank · unranked

0 citations

Brooke McGinley, Carlee Moser, Jonathan Z. Li, Teresa H. Evering, Justin Ritz +42 more

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

UNC Libraries(2025)10.17615/ryrv-wq75

N/A

0DataRank · unranked

0 citations

Yan Li, Jonathan Z. Li, Rachel Bender Ignacio, Kara W Chew, Bharat Mocherla +23 more

STAKEHOLDER ENGAGEMENT IN A COMPARATIVE EFFECTIVENESS/IMPLEMENTATION STUDY TO PREVENT CA-MRSA INFECTION RECURRENCE: CA-MRSA Project (CAMP2)

medRxiv(2020)10.1101/2020.07.15.20147496

N/A

0DataRank · unranked

2 citations

Jessica Ramachandran, Chamanara Khalida, Johana Gonzalez, Rhonda G. Kost, Kimberly S. Vasquez +10 more

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios and Cardiovascular Risk in HIV

medRxiv(2025)10.1101/2025.11.21.25340769

N/A

0DataRank · unranked

0 citations

Ying Tian, Megha Khatri Arora, Takreem Ahmed, Mariam A. Siyanbola, Alondra M. Torres González +4 more

Social and Clinical Determinants of COVID-19 Outcomes: Modeling Real-World Data from a Pandemic Epicenter

medRxiv(2021)10.1101/2021.04.06.21254728

N/A

0DataRank · unranked

11 citations

Sajjad Abedian, Rachel Martini, Scott Kulm, Mirella Salvatore, Kaylee Ho +13 more

The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment

Frontiers in Cellular Neuroscience(2023)10.3389/fncel.2023.1130938

N/A

0DataRank · unranked

22 citations

Teresa H. Evering, Albert M. Anderson, Ann Ragin, Cynthia L. Monaco, Christina Gavegnano +5 more

Molecular Epidemiologic and Geo-Spatial Characterization of Staphylococcus aureus Cultured from Skin and Soft Tissue Infections from United States-Born and Immigrant Patients Living in New York City

Antibiotics(2023)10.3390/antibiotics12101541

N/A

0DataRank · unranked

2 citations

Xiting Lin, Ruijin Geng, Mike Edelson, Fatima Ali, Chaohua Li +11 more

Cellular rejuvenation to combat HIV-1-related neurocognitive impairment

Trends in Microbiology(2023)10.1016/j.tim.2023.09.011

N/A

0DataRank · unranked

2 citations

Teresa H. Evering, Philipp Niklas Ostermann

Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019

UNC Libraries(2023)10.17615/x7r0-1v04

N/A

0DataRank · unranked

0 citations

Joseph J. Eron, Kara W Chew, Michael D. Hughes, Carlee Moser, Judy Currier +12 more

Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19

UNC Libraries(2023)10.17615/ra63-p116

N/A

0DataRank · unranked

0 citations

Jonathan Z. Li, Carlee Moser, Arzhang Cyrus Javan, Judy Currier, Michael D. Hughes +12 more

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae192

N/A

0DataRank · unranked

7 citations

Rinki Deo, Teresa H. Evering, Kara W Chew, Mark J Giganti, Carlee Moser +17 more

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102787

N/A

0DataRank · unranked

3 citations

Carlee Moser, Nikolaus Jilg, Justin Ritz, David A. Wohl, Jonathan Z. Li +89 more

The impact of aging on HIV-1-related neurocognitive impairment

Ageing Research Reviews(2024)10.1016/j.arr.2024.102513

N/A

0DataRank · unranked

7 citations

Teresa H. Evering, Philipp Niklas Ostermann